High levels of autoantibodies against catalase and superoxide dismutase in nasopharyngeal carcinoma

Southern Medical Journal

Volumn 102, Issue 12, 2009, Pages 1222-1226

  Gargouri, Bochra ^a   Lassoued, Saloua ^a   Ben Mansour, Riadh ^a   Ayadi, Wajdi ^a   Idriss, Nabil ^a   Attia, Hammadi ^a   El Feki, Abd El Fatteh ^a  

^a NONE

Author keywords

Autoantibodies; Catalase; Epstein Barr virus; Nasopharyngeal carcinoma; Superoxide dismutase

Indexed keywords

AUTOANTIBODY; CATALASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SUPEROXIDE DISMUTASE; VIRUS CAPSID ANTIGEN; CAPSID PROTEIN; EPSTEIN BARR VIRAL CAPSID ANTIGEN; EPSTEIN-BARR VIRAL CAPSID ANTIGEN; TUMOR MARKER; VIRUS ANTIGEN;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; NASOPHARYNX CARCINOMA; OXIDATIVE STRESS; SEROLOGY; BLOOD; CARCINOMA; ENZYMOLOGY; EPSTEIN BARR VIRUS INFECTION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; VIROLOGY;

ANTIGENS, VIRAL; AUTOANTIBODIES; CAPSID PROTEINS; CARCINOMA; CATALASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; SUPEROXIDE DISMUTASE; TUMOR MARKERS, BIOLOGICAL;

EID: 73949105571     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181bb85b5     Document Type: Article

References (35)

1. Boussen H, Bouaouina N, Mokni-Baizig N, et al. [Nasopharyngeal carcinoma.] Recent data. Pathol Biol (Paris) 2005;53:45-51 [in French].
2. Evans JL, Goldfine ID, Maddux BA, et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1-8.
3. Sies H. Role of reactive oxygen species in biological processes. Klin Wochenschr 1991;69:965-968.
4. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
5. Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human disease. Clin Biochem 1999;1411:385-400.
6. Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative disease. Science 1983;221:1256-1264.
7. Raab-traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 1992;3:297-307.
8. Middeldorp JM, Brink AA, van den Brule AJ, et al. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 2003;45:1-36.
9. Henle G, Henle W. Epstein-Barr-Virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17:1-7.
10. Rickinson AB, Kieff E. Eptein-Barr Virus, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincot-Raven Publishers, 1996, pp 2397-2446.
11. Jalbout M, Bel Hadj Jrad B, Bouaouina N, et al. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 2002;101:146-150.
12. Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008;41:298-328.
13. Ritter K, Kühl RJ, Semrau F, et al. Manganese superoxide dismutase as a target of auto-antibodies in acute Epstein-Barr virus infection. J Exp Med 1994;180:1995-1998.
14. Semrau F, Kühl RJ, Ritter S, et al. Manganese superoxide dismutase (MnSOD) and auto-antibodies against MnSOD in acute viral infection. J Med Virol 1998;55:161-167.
15. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
16. Markland S, Markland G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
17. Henle W, Henle G, Zajac BA, et al. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 1970; 169:188-190.
18. Jiang X, Chen F. The effect of lipid peroxides and superoxide dismutase in systemic lupus erythematosus: a preliminary study. Clin immunol immunopathol 1992;63:39-44.
19. Winterbourn CC, Stern A. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 1987;80:1486-1491.
20. Marklund SL. Expression of extracellular superoxide dismutase by human cell lines. Biochem J 1990;266:213-219.
21. Taysi S, Kocer I, Memisogullari R, et al. Serum oxidant/antioxidant status in patients with Behçet's disease. Ann Clin Lab Sci 2002;32:377-382. (Pubitemid 35340442)
22. Yasmineh WG, Parkin JL, Caspers JI, et al. Tumor necrosis factor/ cachectin decreases catalase activity of rat liver. Cancer Res 1991;51: 3990-3995.
23. Karlsson K, Marklund SL. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J 1987;242: 55-59.
24. Kokkaliari M, Fawibe O, Berry H, et al. Serum catalase as the protective agent against inactivation of alpha 1-proteinase inhibitor by hydrogen peroxide; comparison between normal and rheumatoid sera. Biochem Int 1992;28:219-227.
25. Su Y, Xia YF, Yang HL, et al. [Changes of superoxide dismutase (SOD) and metallothionien (MT) before, during, and after radiotherapy for nasopharyngeal carcinoma and their significance.] Ai Zheng 2003;22: 629-633 [in Chinese].
26. Zhang M, Liu L, Cheng L, et al. [Express of plasma ROS, SOD and GSH-PX in patients with nasopharyngeal carcinoma.] Lin Chuang Er Bi Yan Hou Ke Za Zhi 2003;17:650-651 [in Chinese].
27. Schaade L, Meilicke R, Büttgen S, et al. [Manganese superoxide dismutase-inhibiting auto-antibodies in cholestatic Epstein-Barr viral hepatitis.] Dtsch Med Wochenschr 1998;123:1478-1482 [in German].
28. Karray H, Ayadi W, Fki L, et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 2005;75: 593-602.
29. Fujiwara N, Nakano M, Kato S, et al. Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem 2007;282:35933-35944.
30. Orth T, Kellner R, Diekmann O, et al. Identification and characterization of auto-antibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998;112:507-515.
31. Roozendaal C, Zhao MH, Horst G, et al. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol 1998;1:10-16.
32. Mansour RB, Lassoued S, Gargouri B, et al. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 2008;37:103-108.
33. D'souza A, Kurien BT, Rodgers R, et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 2008;9:62.
34. Gargouri B, Van Pelt J, El feki A, et al. Induction of Epstein Barr Virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoïde B cell lines. Mol Cell Biochem 2009;324:55-63.
35. Lassoued S, Ben Ameur R, Ayadi W, et al. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Biochem 2008;313: 179-186.